FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387081057> ?p ?o ?g. }

• W4387081057 endingPage "115587" @default.
• W4387081057 startingPage "115587" @default.
• W4387081057 abstract "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive inflammation and fibrosis around intrahepatic and extrahepatic bile ducts leading to severe hepatic cirrhosis and high mortality. Although there is an urgent clinical unmet need for PSC, no effective medical therapy has been developed to delay the disease progression until today. IL-18 binding protein (IL-18BP) is well-known to be a natural negative feedback regulator for IL-18, and we have developed a recombinant long-acting IL-18BP referred to as APB-R3 as a therapeutic agent to treat IL-18-related inflammatory diseases. Here, we aimed to study whether disrupted IL-18 signaling by APB-R3 treatment can inhibit PSC injuries in the experimental DDC diet-induced PSC rodent model. First, we found that the amounts of free IL-18 are augmented under PSC condition with increased expression of biliary IL-18 receptors. Administration of APB-R3 effectively attenuated key diagnostic parameters of PSC such as plasma ALP and GGT levels as well as bile acids levels. We also observed that blockade of IL-18 suppressed ductular reactive and proliferative phenotypes of cholangiocytes. Additionally, APB-R3 significantly ameliorated DDC diet-induced periductal fibrosis and transcriptional expressions of pro-fibrotic marker genes. Enhanced senescence associated secretory phenotype (SASP) markers in cholestatic liver disease were diminished by APB-R3 treatment. Our findings clearly demonstrate that the administration of IL-18BP biologics, APB-R3, effectively alleviates DDC diet-induced biliary injuries in rodent PSC model, implying APB-R3 can be a promising therapeutic reagent which warrants clinical human trials as new therapeutic options." @default.
• W4387081057 created "2023-09-28" @default.
• W4387081057 creator A5015193968 @default.
• W4387081057 creator A5017067532 @default.
• W4387081057 creator A5023037751 @default.
• W4387081057 creator A5030263392 @default.
• W4387081057 creator A5041402705 @default.
• W4387081057 creator A5043375588 @default.
• W4387081057 creator A5046404472 @default.
• W4387081057 creator A5070016600 @default.
• W4387081057 creator A5085660248 @default.
• W4387081057 creator A5091728770 @default.
• W4387081057 date "2023-11-01" @default.
• W4387081057 modified "2023-10-18" @default.
• W4387081057 title "Disruption of IL-18 signaling via engineered IL-18BP biologics alleviates experimental cholestatic liver disease" @default.
• W4387081057 cites W1555526329 @default.
• W4387081057 cites W1819325258 @default.
• W4387081057 cites W1966349839 @default.
• W4387081057 cites W1973047647 @default.
• W4387081057 cites W1977135749 @default.
• W4387081057 cites W2095698281 @default.
• W4387081057 cites W2117361576 @default.
• W4387081057 cites W2133403920 @default.
• W4387081057 cites W2184709292 @default.
• W4387081057 cites W2409346695 @default.
• W4387081057 cites W2557633607 @default.
• W4387081057 cites W2600916727 @default.
• W4387081057 cites W2786456523 @default.
• W4387081057 cites W2790830382 @default.
• W4387081057 cites W2899751126 @default.
• W4387081057 cites W2910565776 @default.
• W4387081057 cites W2917357185 @default.
• W4387081057 cites W2921998529 @default.
• W4387081057 cites W2922442234 @default.
• W4387081057 cites W2951114548 @default.
• W4387081057 cites W2991106121 @default.
• W4387081057 cites W2994838445 @default.
• W4387081057 cites W3011514631 @default.
• W4387081057 cites W3045523376 @default.
• W4387081057 cites W3204507277 @default.
• W4387081057 cites W4200387055 @default.
• W4387081057 cites W4200431297 @default.
• W4387081057 cites W4211088821 @default.
• W4387081057 cites W4286209270 @default.
• W4387081057 cites W4294606888 @default.
• W4387081057 doi "https://doi.org/10.1016/j.biopha.2023.115587" @default.
• W4387081057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37774670" @default.
• W4387081057 hasPublicationYear "2023" @default.
• W4387081057 type Work @default.
• W4387081057 citedByCount "0" @default.
• W4387081057 crossrefType "journal-article" @default.
• W4387081057 hasAuthorship W4387081057A5015193968 @default.
• W4387081057 hasAuthorship W4387081057A5017067532 @default.
• W4387081057 hasAuthorship W4387081057A5023037751 @default.
• W4387081057 hasAuthorship W4387081057A5030263392 @default.
• W4387081057 hasAuthorship W4387081057A5041402705 @default.
• W4387081057 hasAuthorship W4387081057A5043375588 @default.
• W4387081057 hasAuthorship W4387081057A5046404472 @default.
• W4387081057 hasAuthorship W4387081057A5070016600 @default.
• W4387081057 hasAuthorship W4387081057A5085660248 @default.
• W4387081057 hasAuthorship W4387081057A5091728770 @default.
• W4387081057 hasBestOaLocation W43870810571 @default.
• W4387081057 hasConcept C104317684 @default.
• W4387081057 hasConcept C126322002 @default.
• W4387081057 hasConcept C127716648 @default.
• W4387081057 hasConcept C203014093 @default.
• W4387081057 hasConcept C2776637226 @default.
• W4387081057 hasConcept C2776914184 @default.
• W4387081057 hasConcept C2777075537 @default.
• W4387081057 hasConcept C2777214474 @default.
• W4387081057 hasConcept C2779134260 @default.
• W4387081057 hasConcept C2780366471 @default.
• W4387081057 hasConcept C2780559512 @default.
• W4387081057 hasConcept C2780615123 @default.
• W4387081057 hasConcept C502942594 @default.
• W4387081057 hasConcept C55493867 @default.
• W4387081057 hasConcept C71924100 @default.
• W4387081057 hasConcept C86803240 @default.
• W4387081057 hasConceptScore W4387081057C104317684 @default.
• W4387081057 hasConceptScore W4387081057C126322002 @default.
• W4387081057 hasConceptScore W4387081057C127716648 @default.
• W4387081057 hasConceptScore W4387081057C203014093 @default.
• W4387081057 hasConceptScore W4387081057C2776637226 @default.
• W4387081057 hasConceptScore W4387081057C2776914184 @default.
• W4387081057 hasConceptScore W4387081057C2777075537 @default.
• W4387081057 hasConceptScore W4387081057C2777214474 @default.
• W4387081057 hasConceptScore W4387081057C2779134260 @default.
• W4387081057 hasConceptScore W4387081057C2780366471 @default.
• W4387081057 hasConceptScore W4387081057C2780559512 @default.
• W4387081057 hasConceptScore W4387081057C2780615123 @default.
• W4387081057 hasConceptScore W4387081057C502942594 @default.
• W4387081057 hasConceptScore W4387081057C55493867 @default.
• W4387081057 hasConceptScore W4387081057C71924100 @default.
• W4387081057 hasConceptScore W4387081057C86803240 @default.
• W4387081057 hasLocation W43870810571 @default.
• W4387081057 hasLocation W43870810572 @default.
• W4387081057 hasOpenAccess W4387081057 @default.
• W4387081057 hasPrimaryLocation W43870810571 @default.

• next